Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

PROMACTA for Hepatitis c: Side Effects & Safety Data

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

There are 10 adverse event reports in the FDA FAERS database where PROMACTA was used for Hepatitis c.

Most Reported Side Effects for PROMACTA

Side Effect Reports % Deaths Hosp.
Platelet count decreased 34 11.5% 0 9
Death 29 9.8% 29 5
Drug ineffective 26 8.8% 1 4
Investigation 17 5.7% 1 17
Nausea 16 5.4% 0 0
Diarrhoea 13 4.4% 0 2
Headache 12 4.0% 0 1
Platelet count increased 12 4.0% 0 3
Treatment noncompliance 12 4.0% 0 2
Fatigue 11 3.7% 0 2
Abdominal pain upper 9 3.0% 1 1
Pain in extremity 8 2.7% 0 1
Rash 8 2.7% 0 0
Asthenia 7 2.4% 0 1
Dizziness 7 2.4% 0 1

Other Indications for PROMACTA

Immune thrombocytopenic purpura (102) Product used for unknown indication (88) Thrombocytopenia (29) Platelet count decreased (15) Chronic hepatitis c (5)

Other Drugs Used for Hepatitis c

RIBAVIRIN (20,657) PEGINTERFERON ALFA-2A (10,970) LEDIPASVIR\SOFOSBUVIR (8,924) DASABUVIR\OMBITASVIR\PARITAPREVIR\RITONAVIR (8,264) SOFOSBUVIR (7,691) SOFOSBUVIR\VELPATASVIR (4,956) GLECAPREVIR\PIBRENTASVIR (4,016) OMBITASVIR\PARITAPREVIR\RITONAVIR (2,906) TELAPREVIR (2,604) DASABUVIR (2,603)

Related Pages

PROMACTA Full Profile All Hepatitis c Drugs PROMACTA Demographics PROMACTA Timeline